Astellas Pharma Stock Today
| ALPMF Stock | USD 9.50 0.25 2.56% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Astellas Pharma is trading at 9.50 as of the 25th of April 2024. This is a -2.56 percent decrease since the beginning of the trading day. The stock's lowest day price was 9.5. Astellas Pharma has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Astellas Pharma are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. Astellas Pharma Inc. was founded in 1923 and is headquartered in Tokyo, Japan. ASTELLAS PHARMA operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. The company has 1.83 B outstanding shares. More on Astellas Pharma
Moving together with Astellas Pink Sheet
| 0.76 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.66 | RHHBY | Roche Holding | PairCorr |
| 0.64 | RHHVF | Roche Holding AG | PairCorr |
Moving against Astellas Pink Sheet
| 0.77 | CPNG | Coupang LLC Financial Report 14th of May 2024 | PairCorr |
| 0.63 | HAS | Hasbro Inc Upward Rally | PairCorr |
| 0.62 | GERN | Geron Financial Report 9th of May 2024 | PairCorr |
| 0.6 | META | Meta Platforms | PairCorr |
| 0.58 | PH | Parker Hannifin Earnings Call This Week | PairCorr |
| 0.52 | DIS | Walt Disney Report 8th of May 2024 | PairCorr |
| 0.48 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Astellas Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Astellas Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Astellas Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Yoshihiko Hatanaka |
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Astellas Pharma [ALPMF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Large-Cap' category with a current market capitalization of 26.66 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Astellas Pharma's market, we take the total number of its shares issued and multiply it by Astellas Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Astellas Pharma classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.83 B outstanding shares.
Astellas Pharma has accumulated about 336.76 B in cash with 257.44 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 184.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Astellas Pharma Probability Of Bankruptcy
Ownership AllocationAstellas Pharma holds a total of 1.83 Billion outstanding shares. Over half of Astellas Pharma's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Astellas Pharma. Please watch out for any change in the institutional holdings of Astellas Pharma as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Astellas Ownership Details
Astellas Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Astellas Pharma jumping above the current price in 90 days from now is about 98.0%. The Astellas Pharma probability density function shows the probability of Astellas Pharma pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Astellas Pharma has a beta of 0.475. This suggests as returns on the market go up, Astellas Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Astellas Pharma will be expected to be much smaller as well. Additionally, astellas Pharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Astellas Pharma to move above the current price in 90 days from now is about 98.0 (This Astellas Pharma probability density function shows the probability of Astellas Pink Sheet to fall within a particular range of prices over 90 days) .
Astellas Pharma Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Astellas Pharma market risk premium is the additional return an investor will receive from holding Astellas Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Astellas Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Astellas Pharma's alpha and beta are two of the key measurements used to evaluate Astellas Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.72 | |||
| Standard Deviation | 2.72 | |||
| Variance | 7.41 | |||
| Risk Adjusted Performance | (0.07) |
Astellas Stock Against Markets
Picking the right benchmark for Astellas Pharma pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Astellas Pharma pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Astellas Pharma is critical whether you are bullish or bearish towards Astellas Pharma at a given time. Please also check how Astellas Pharma's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Astellas Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Astellas Pharma Corporate Directors
Astellas Pharma corporate directors refer to members of an Astellas Pharma board of directors. The board of directors generally takes responsibility for the Astellas Pharma's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Astellas Pharma's board members must vote for the resolution. The Astellas Pharma board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Yutaka Kase | Independent Director | Profile | |
| Hironobu Yasuda | Independent Director | Profile | |
| Naoki Okamura | Executive Officer, Director of Business Planning | Profile | |
| Eisuke Nozawa | Executive Officer, Director of Pharmaceutical Affairs | Profile |
How to buy Astellas Pink Sheet?
Before investing in Astellas Pharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Astellas Pharma. To buy Astellas Pharma stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Astellas Pharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Astellas Pharma stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Astellas Pharma stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Astellas Pharma stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Astellas Pharma, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Astellas Pharma?
The danger of trading Astellas Pharma is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Astellas Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Astellas Pharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Astellas Pharma is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astellas Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Astellas Pink Sheet analysis
When running Astellas Pharma's price analysis, check to measure Astellas Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astellas Pharma is operating at the current time. Most of Astellas Pharma's value examination focuses on studying past and present price action to predict the probability of Astellas Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astellas Pharma's price. Additionally, you may evaluate how the addition of Astellas Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stocks Directory Find actively traded stocks across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |